Welcome to our Alpha hub InnoFluidics!
InnoFluidics aims to reduce the cancer burden by providing innovative technologies. InnoFluidics' rare cell analysis platform will purify and collect tumor cells circulating in the blood with a simple blood test. Since these cells contain all the information about the disease, our patented technology will help specialists in their clinical decision-making and be used as a tool for drug development. We have proven the validity of our approach with model samples and are now working on building a prototype that will be tested in clinics.
